TA179: Gastrointestinal stromal tumours - sunitinib
This is a discussion on TA179: Gastrointestinal stromal tumours - sunitinib within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Gastrointestinal stromal tumours - sunitinib. It links to the published guidance and key ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
09-22-2009, 08:06 PM
|
|||
|
|||
TA179: Gastrointestinal stromal tumours - sunitinib
The summary for the published technology appraisal on Gastrointestinal stromal tumours - sunitinib. It links to the published guidance and key documents.
More... Last edited by chantell.reagan : 09-24-2009 at 01:41 PM. 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA169: Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma | industry_news | Updates from the Technology Assessment Authorities | 0 | 03-24-2009 09:20 PM |
| Bevacizumab/Sunitinib Clinical Trials Halted Due to Anemia Cases | industry_news | Other Clinical Pharmacy News | 0 | 07-15-2008 11:16 AM |
| SSRIs and Venlafaxine Linked to Greater Risk for Gastrointestinal Tract Bleeding | industry_news | Other Clinical Pharmacy News | 0 | 07-14-2008 06:31 PM |
| Heart Failure Linked to Sunitinib Treatment | industry_news | Other Clinical Pharmacy News | 0 | 07-03-2008 04:02 PM |
| Off-Label Uses of Sorafenib and Sunitinib | industry_news | Updates from the Technology Assessment Authorities | 0 | 03-10-2008 04:01 PM |
© 2008 DrugManagementForum™ powered by |
 |